Description
| Summary: | This new edition features updated information on all aspects of the diagnosis and management of ovarian cancer. Embracing knowledge from around the world, this multidisciplinary book discusses current approaches to ovarian cancer that have helped stabilize the rate of both incidences and fatality for the disease. The chapters focus on genetic screening and advances in management, including the optimization of chemotherapeutic agents, gene therapy, and the latest laparoscopic and robotic surgical techniques. Further chapters address psychosocial and quality-of-life issues as well. The book is a must-have resource for wide range of practitioners who care for patients with ovarian cancer and researchers who study the disease.
|
|---|
| Item Description: | Includes index. |
|---|
| Physical Description: | 1 online resource : illustrations (black and white, and color). |
|---|
| Bibliography: | References -- 4: Hereditary Ovarian Cancer -- Background -- BRCA1 and BRCA2 Mutations -- Prevalence -- Cancer Risks -- Screening and Risk-Reducing Surgery -- Phenotype -- Treatment -- PARP Inhibitors -- Resistance and Super-Responders -- Survival -- Lynch Syndrome -- Prevalence and Phenotype -- Risk -- Second Cancer Risk -- Ovarian Cancer Screening -- Aspirin Use -- Implications for Treatment -- Other Homologous Recombination Genes -- BRIP1 -- RAD51C -- RAD51D -- Non-epithelial Ovarian Cancer -- DICER1 -- Small Cell Cancer of the Ovary, Hypercalcaemic Type (SCCOHT) -- Conclusion -- References |
|---|
| ISBN: | 9783031091698
3031091698 |
|---|
| Source of Description, Etc. Note: | Print version record. |
|---|